Publicacións en colaboración con investigadores/as de Pfizer (United States) (4)

2021

  1. The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer

    Breast Cancer Research and Treatment, Vol. 187, Núm. 1, pp. 155-165

2014

  1. Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer

    Journal of Clinical Oncology, Vol. 32, Núm. 32, pp. 3626-3634

2013

  1. Randomized phase II study of sunitinib versus standard of care forpatients with previously treated advanced triple-negative breastcancer

    Breast, Vol. 22, Núm. 5, pp. 650-656

2012

  1. First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study

    Journal of Clinical Oncology, Vol. 30, Núm. 9, pp. 921-929